MARKET WIRE NEWS
  1. Home
  2. Stock
  3. KALV
  4. News
KALV
Quote
Short
News
Articles
Message Board

KalVista Pharmaceuticals Inc. (NASDAQ : KALV ) News

KalVista Pharmaceuticals Inc. (NASDAQ: KALV) News Releases

KALV News Releases
KALV : NASDAQ
SeekingAlpha
Small-cap healthcare stocks with A+ grade EPS revisions ahead of earnings
KALV : NASDAQ
Business Wire
KalVista Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference
KALV : NASDAQ
SeekingAlpha
KalVista Pharmaceuticals: Ekterly's Launch Momentum Keeps The Bull Case Alive
KALV : NASDAQ
Business Wire
KalVista Pharmaceuticals Announces Positive Interim Phase 3 Data From KONFIDENT-KID Trial of EKTERLY® (sebetralstat) for Children Aged 2-11 Years at the 2026 Global Angioedema Leadership Conference
KALV : NASDAQ
SeekingAlpha
KalVista Pharmaceuticals, Inc. (KALV) 8 Months 2025 Earnings Call Transcript
KALV : NASDAQ
SeekingAlpha
KalVista Pharmaceuticals beats Q4 topline estimates
KALV : NASDAQ
Business Wire
KalVista Pharmaceuticals Reports Eight Months Fiscal Year 2025 Financial Results and Provides Corporate Update
KALV : NASDAQ
SeekingAlpha
KalVista Pharmaceuticals Q4 2025 Earnings Preview
KALV : NASDAQ
SeekingAlpha
Quant snapshot: AAR, Noah Holdings lead strong buys as Blaize, Fractyl Health lag
KALV : NASDAQ
Business Wire
KalVista Pharmaceuticals to Present New EKTERLY® (sebetralstat) Data at the 2026 Global Angioedema Leadership Conference

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.